Cargando…

Diabetic Retinopathy and VEGF

Diabetic retinopathy remains the leading vascular-associated cause of blindness throughout the world. Its treatment requires a multidisciplinary interventional approach at both systemic and local levels. Current management includes laser photocoagulation, intravitreal steroids, and anti-vascular end...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, N, Mansoor, S, Sharma, A, Sapkal, A, Sheth, J, Falatoonzadeh, P, Kuppermann, BD, Kenney, MC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580758/ https://www.ncbi.nlm.nih.gov/pubmed/23459241 http://dx.doi.org/10.2174/1874364101307010004

Ejemplares similares

2-ethylpyridine, a cigarette smoke component, causes mitochondrial damage in human retinal pigment epithelial cells in vitro
por: Mansoor, S, et al.
Publicado: (2014)

Effects of Benzo(e)pyrene on Reactive Oxygen/Nitrogen Species and Inflammatory Cytokines Induction in Human RPE Cells and Attenuation by Mitochondrial-involved Mechanism
por: Estrago-Franco, M. Fernanda, et al.
Publicado: (2016)

Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2012)

Protective Effects of 17β-Estradiol on Benzo(e) pyrene[B(e)P]-induced Toxicity in ARPE-19 cells
por: Sapkal, Ashish U., et al.
Publicado: (2018)

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
por: Kuiper, Esther J., et al.
Publicado: (2008)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy
por: Wu, Yuexiu, et al.
Publicado: (2010)

Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
por: Lai, Meihua, et al.
Publicado: (2023)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
por: Bahr, Tyler A., et al.
Publicado: (2023)

Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
por: Bolinger, Mark T., et al.
Publicado: (2016)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020)

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
por: Arrigo, Alessandro, et al.
Publicado: (2022)

Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity
por: McLeod, D Scott, et al.
Publicado: (2016)

Association of VEGF Gene Polymorphisms with Diabetic Retinopathy: A Meta-Analysis
por: Gong, Jian-Yang, et al.
Publicado: (2013)

Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness
por: Ozturk, Banu Turgut, et al.
Publicado: (2009)

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy
por: Paine, Suman K., et al.
Publicado: (2017)

Associations of VEGF Polymorphisms With Retinopathy of Prematurity
por: Ling, Xiao Chun, et al.
Publicado: (2023)

Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro
por: Sharma, Ashish, et al.
Publicado: (2014)

VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis
por: Wu, Rensiqin, et al.
Publicado: (2020)

Anti-VEGF Drugs Influence Epigenetic Regulation and AMD-Specific Molecular Markers in ARPE-19 Cells
por: Hamid, Mohamed A., et al.
Publicado: (2021)

Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
por: Pramanik, Subhasish, et al.
Publicado: (2021)

Examining the Role of Telemedicine in Diabetic Retinopathy
por: Land, Matthew R., et al.
Publicado: (2023)

Molecular Imaging of Subclinical Diabetic Retinopathy
por: Russmann, Christoph, et al.
Publicado: (2017)

Leukostasis retinopathy treated with Anti-VEGF therapy
por: Shakibai, Nasim, et al.
Publicado: (2020)

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture
por: Malik, Deepika, et al.
Publicado: (2014)

Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy
por: Chen, Bin, et al.
Publicado: (2017)

Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy
por: Rossino, Maria Grazia, et al.
Publicado: (2020)

TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
por: Bonfiglio, Vincenza, et al.
Publicado: (2020)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021)

A review on the effect of garlic on diabetes, BDNF, and VEGF as a potential treatment for diabetic retinopathy
por: Sanie-Jahromi, Fatemeh, et al.
Publicado: (2023)

Protective effects of lipoic acid on chrysene-induced toxicity on Müller cells in vitro
por: Mansoor, Saffar, et al.
Publicado: (2013)

Differential Epigenetic Status and Responses to Stressors between Retinal Cybrids Cells with African versus European Mitochondrial DNA: Insights into Disease Susceptibilities
por: Atilano, Shari R., et al.
Publicado: (2022)

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012)

Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients
por: Izuta, Hiroshi, et al.
Publicado: (2009)

Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
por: Zhao, Yue, et al.
Publicado: (2020)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Inhibition of KCTD10 Affects Diabetic Retinopathy Progression by Reducing VEGF and Affecting Angiogenesis
por: Feng, Yun, et al.
Publicado: (2022)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dnqkd6kj8ge9jvfdbqc64knhg8